GSK ponders legal action on KFDA's administrative disposition

GlaxoSmithKline said it is now reviewing various ways to run counter to the November 23 administrative disposition for false ads of its flu vaccine Fluarix, meted out by the Korea Food and Drug Administration, adding it is quite regretful and disappointed that the FDA imposed a certain amount of fines to GSK on grounds of false or exaggerated ads for Fluarix vaccine, albeit our repeated stateme...